Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.56 |
| ▸ | CA2 | P00918 | 2/20 | 0.56 |
| ▸ | EGFR | P00533 | 1/20 | 0.40 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.39 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.39 |
| ▸ | GLRA3 | O75311 | 1/20 | 0.39 |
| ▸ | GLRB | P48167 | 1/20 | 0.39 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.36 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.35 |
| ▸ | RARA | P10276 | 1/20 | 0.35 |
| ▸ | RARB | P10826 | 1/20 | 0.35 |
| ▸ | RARG | P13631 | 1/20 | 0.35 |
| ▸ | APEX1 | P27695 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | ESRRA | P11474 | 1/20 | 0.34 |
| ▸ | ERN1 | O75460 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9359090 | 0.81 | USP2 (0.45) | CA1CA2GAAERN1 | |
| SCHEMBL311610 | 0.79 | CA1 (0.67) | CA1CA2EGFRGABBR2GABBR1 | |
| SCHEMBL30186532 | 0.79 | CA1 (0.67) | CA1CA2EGFRGABBR2GABBR1 | |
| SCHEMBL544833 | 0.74 | CA1 (0.56) | CA1CA2EGFRGABBR2GABBR1 | |
| SCHEMBL39130 | 0.74 | CA2 (1.00) | CA1CA2EGFRALDH1A1GAA | |
| SCHEMBL11303373 | 0.73 | GABBR2 (0.58) | CA1CA2EGFRGABBR2GABBR1 | |
| SCHEMBL11303376 | 0.73 | GABBR2 (0.58) | CA1CA2EGFRGABBR2GABBR1 | |
| SCHEMBL544906 | 0.73 | ERN1 (0.60) | CA1CA2ALDH1A1ERN1 | |
| SCHEMBL544908 | 0.73 | ERN1 (0.60) | CA1CA2ALDH1A1ERN1 | |
| SCHEMBL12673513 | 0.72 | GPR55 (0.45) | CA1CA2GLRA3GLRBVCAM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8110589-B2 | Ectoparasiticide composition and a method for exterminating extoparasites | KYOYU AGRI CO., LTD. (JP) | 2012-02-07 | — | — | US | disclosed |
| US-20090312378-A1 | ECTOPARASITICIDE COMPOSITION AND A METHOD FOR EXTERMINATING ECTOPARASITES | YASHIMA SANGYO CO., LTD. (JP) | 2009-12-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090312378-A1 | ECTOPARASITICIDE COMPOSITION AND A METHOD FOR EXTERMINATING ECTOPARASITES | EPX, TYR, PPOX | CA1 4517/4885CA2 3886/4885EGFR 4623/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.